Anoro Ellipta (Umeclidinium Bromide/Vilanterol Trifenatate) is a NEW prescription inhalation powder drug used by patients with COPD including chronic bronchitis and/or emphysema. This is a long-term once daily maintenance treatment of airflow obstruction in patients. Anoro Ellipta must be used regularly to be effective. This medication does not work immediately and should not be used to relieve sudden shortness of breath.
Manufacturer Information
We currently have the brand from Canada manufactured by GSK. This medication is available in the strength of 62.5mcg/25mcg/30 dose inhaler. Our Canadian Pharmacy also carries other COPD medications such as
Breo Ellipta and
Stiolto Respimat
Common side effects include:
• Cold symptoms;
• Constipation;
• Diarrhea;
• Lower respiratory infection;
• Muscle spasms;
• Pain in the neck, arms or legs;
• Sinus infection;
• Sore throat
Serious side effects include:
• Chest pain;
• Fainting;
• Feeling dizzy
• Irregular heartbeat
This medication should not be used for asthma. You should not use Anoro Ellipta if you have a severe allergy to milk proteins or if you are allergic to umeclidinium, vilanterol, or if you have any other allergies. Before you start using this medication, inform your doctor about your medical condition and about all the medications you are currently taking including OTC and herbal medications. This medication should not be used in patients under 18 years of age. There may be an interaction between Anoro Ellipta and other medications such as ipratropium, tiotropium, formoterol, salmeterol, etc.
Blog Post
Spotlight: New Drugs Hitting the 2016 Pharmaceutical Market